Bulletin of Experimental Treatments for AIDS (BETA), published by the San Francisco AIDS Foundation, is one of the most comprehensive HIV treatment publications, with hundreds of in-depth articles.

BETA is published quarterly by the San Francisco AIDS Foundation.

BETA
Main page

Subscribe (free)

Contact Us
beta@sfaf.org

 

 

January 1999 Table of Contents

Features

Policy Issues Related to New Metabolic Abnormalities in HIV Disease

The Challenge of Adherence: A Talk by Margaret Chesney
Adherence to HAART: An Interview with William Holzemer
Body Fat Change: More than Lipodystrophy
Opportunistic Infections: Is It Safe to Stop Prophylaxis?

Departments

BETA News Briefs

Drug Watch
-- T-20: First of a New Class of Anti-HIV Drugs
-- Amprenavir: A New Protease Inhibitor Nears Approval

Women and HIV
-- Strategies for Preventing Late-Term Vertical HIV Transmission
Conference Coverage
-- Highlights from Recent Conferences
Glossary

Notice

The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.

Contributors to this issue:

  • Ronald Baker, PhD
  • Harvey S. Bartnof, MD
  • Jill Cadman
  • Margaret Chesney, PhD
  • Leslie Hanna
  • Liz Highleyman
  • Tadd Tobias
  • David Townley

Page last updated 15 January 1999


About AIDS | Treatment | Prevention | Policy | About SFAF | Take Action | Donate
 Espaņol | Search | Site Map | Feedback | Email Updates | Home (sfaf.org)